Gepirone: A New Extended-Release Oral Selective Serotonin Receptor Agonist for Major Depressive Disorder
{{output}}
Objective: To evaluate the safety, efficacy, and tolerability of gepirone (Exxua) in the treatment of adult patients with major depressive disorder. Data Sources: A literature search was performed through PubMed, Embase, and PsycINFO using the following terms:... ...
